Materials • Major Chemicals
$6.99 ▼ -0.05
(-0.71%)
MKT CAP: $341.8M • VOL: 13.3K
52W L $5 52W H $9
ROARABLE / RQD
D • 44/100
PIOTROSKI
4 / 9
NL // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $158.3M | $145.9M | $161.3M |
| YoY Revenue Growth % | +8.5% | -9.5% | — |
| Gross Profit | $48.2M | $41.4M | — |
| Gross Margin % | 30.4% | 28.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $10.7M | $37.9M | $14.1M |
| Operating Margin % | 6.7% | 26.0% | 8.8% |
| Net Income (GAAP) | -$37.8M | $67.2M | -$2.3M |
| EBITDA (Normalized) | $13.7M | $39.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$36.4M | $25.6M | $37.0M |
| Capital Expenditures (CapEx) | $3.7M | $1.4M | — |
| Free Cash Flow (FCF) | -$40.1M | $24.1M | $37.0M |
| FCF Margin % | -25.4% | 16.5% | 22.9% |
| Return on Invested Capital (ROIC %) | 3.4% | 12.8% | — |
| Cash & Short-Term Equivalents | $110.6M | $163.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $358.8M | $396.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NL.